PMID: 1195471Dec 1, 1975Paper

Peyronie's disease: results with dermo-jet injection of dexamethasone

The Journal of Urology
C C Winter, R Khanna

Abstract

The results in 21 patients with Peyronie's disease who were managed with a course of dermo-jet percutaneous injections of dexamethasone into the plaques are described herein. These patients had 6 to 10 injections at intervals of 1 month for 6 months. In a high percentage of the cases there occurred a disappearance or decrease in the size of the plaques, pain on erection and discomfort during sexual relations. Also, there was a high rate of improvement in the chordee. Because of the natural history of resolution of the plaques and the small number of patients, statistical significance is not believed applicable, although 71 per cent of the patients had experienced prior failure with other modes of therapy. Eight patients experienced urinary or prostato-epididymal infections at some time in their medical history, correlating well with the inflammatory theory as the cause of the disorder.

References

Apr 1, 1971·The Journal of Urology·E Toksu
Oct 1, 1970·The Journal of Urology·C V Dreyer, C C Winter
Jun 1, 1966·American Journal of Clinical Pathology·B H Smith
Jan 1, 1967·The Journal of Urology·P N Desanctis, C A Furey
Sep 1, 1954·The Journal of Urology·H BODNERJ H KAPLAN

❮ Previous
Next ❯

Citations

Mar 1, 1989·British Journal of Urology·J C Gingell, K M Desai
Nov 1, 1980·Postgraduate Medical Journal·V O Odiase, R H Whitaker
Feb 9, 2007·Nature Clinical Practice. Urology·Yemi Akin-Olugbade, John P Mulhall
Sep 16, 2011·International Journal of Impotence Research·S M Larsen, L A Levine
Aug 6, 2011·Current Urology Reports·Ege Can Serefoglu, Wayne J G Hellstrom
Feb 23, 2019·Therapeutic Advances in Urology·Karen Randhawa, C J Shukla
Feb 24, 2001·Scandinavian Journal of Urology and Nephrology·A LamprakopoulosM Lykourinas
Mar 1, 2008·Expert Review of Clinical Pharmacology·Jason M Greenfield
Dec 10, 1988·BMJ : British Medical Journal·J C Gingell, K M Desai
Apr 18, 2014·Current Urology Reports·Ronny B W TanWayne J G Hellstrom
Dec 19, 2007·Asian Journal of Andrology·Frederick L Taylor, Laurence A Levine
Oct 22, 2005·Current Urology Reports·Gregory S JackJacob Rajfer
Dec 14, 2007·Expert Opinion on Pharmacotherapy·Ahmed I El-Sakka, Aksam A Yassin
Mar 12, 2003·The Journal of Urology·Shahram S GholamiTom F Lue
Mar 14, 2007·Drugs·Landon W TrostWayne J G Hellstrom
May 5, 2021·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·L FerrettiA Faix
Jul 7, 2021·The Journal of Sexual Medicine·Nahid PunjaniJohn P Mulhall

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.